This collaborative article reviews chronic pulmonary aspergillosis (CPA) from the perspective of a multidisciplinary team comprising of respiratory physicians, radiologists, mycologists, dietitians, pharmacists, physiotherapists and palliative care specialists. The review synthesises current knowledge on CPA, emphasising the intricate interplay between clinical, radiological, and microbiological aspects. We highlight the importance of assessing each patient as a multidisciplinary team to ensure personalised treatment strategies and a holistic approach to patient care.
Share this post
Latest News posts
Physiotherapy and Aspergillosis: Why It Matters
December 2, 2025
🌐 Promoting the NHS National Aspergillosis Centre (NAC)
November 27, 2025
⭐ Recent Aspergillosis Research Updates (Week 48)
November 26, 2025
🌿 Biologics when ABPA and CPA overlap: What Patients Need to Know
November 25, 2025
🌍 Does where you live affect aspergillosis or ABPA?
November 25, 2025
News archive
× Close
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- CPA
- Carers & Family
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Research
- NAC Announcements
- Professional Guidance
- Recordings
- Research
- Research Summaries
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel & Insurance
- Treatment
- Vaccines
- Weekly Updates
